HOME >> BIOLOGY >> NEWS
LSU veterinarians deliver cloned calves by caesarian section

BATON ROUGE A team of LSU veterinarians recently delivered two cloned calves by caesarean section at the university's School of Veterinary Medicine.

The veterinarians delivered Mouill and Soleil on different days so they could focus intensely on each calf after its birth.

Mouill, French for "wet," was born on a rainy Monday morning, January 29. Soleil, or "sun," was born the following Tuesday.

The calves were cloned by Cyagra Inc. of Manhattan, Kan., under a trial procedure Cyagra is filing as a new patent. The company brought its cloning technology to LSU in the form of two surrogate cows who gave birth to the Charolais calves. The calves were developed for Lester Colomb of the Colomb Cattle Company of Lafayette, La.

The veterinary school became involved in the project to deliver the calves and to provide the necessary medical treatment in the first critical days. Mouill and Soleil are the seventh and eighth calves cloned by Cyagra since August but are the first cloned through a new process developed by the company.

Cyagra Inc. is a division of Advanced Cell Technology, a company focusing on development of transgenic animal technologies with applications in protein production and cell and organ transplant therapy. Cyagra's research and work focuses on livestock cloning for individual clients that will also further its own research.

According to Audy Spell, director of operations for Cyagra, "Most of the livestock we develop is for clients wanting to replicate something valuable."

Cloning involves transfer of a donor cell into an enucleated oocyte, or cell whose DNA has been extracted. Cyagra then performs numerous procedures to mimic natural occurrences of cell reproduction before the developed embryos are transferred into a surrogate mother who will carry the pregnancy to term.

"The cloning process for Mouill and Soleil is basically the same as our past clones," Spell said. "What was different was the
'"/>

Contact: Kristine Calongne
kcalong@lsu.edu
225-578-5985
Louisiana State University
25-Mar-2001


Page: 1 2 3

Related biology news :

1. Computers help veterinarians diagnosis pets with rare diseases
2. The birth of reproductive health: A difficult delivery
3. Vacuum assisted deliveries are safe alternative to forceps
4. Nerac delivers journal tracking solution through TOC Journal Watch
5. RNAi delivery system crosses blood-brain barrier to target brain cancer
6. Nerac.com to deliver newswire feed twice daily
7. Radiologists provide safe delivery method for gene therapy
8. Study suggests insect-derived antimicrobial peptides could be used as drug-delivery vehicles
9. Nanoparticle probes are destined for major new role in medical diagnostics and drug delivery
10. Steroid-coated DNA represents new approach to gene delivery
11. Smart bomb delivery destroys tumors in mice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: LSU veterinarians deliver cloned calves caesarian section

(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... AUSTIN, Texas , Dec. 16, 2014  Vermillion, ... company focused on gynecologic disease, today announced the next ... into a premier bio-analytics solutions provider with the naming ... to President and Chief Executive Officer, while current Chairman ... will continue to serve as Chairman. These changes are ...
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
Cached News: